Medical - Healthcare Information Services
Compare Stocks
2 / 10Stock Comparison
HTFL vs GEHC
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Information Services
HTFL vs GEHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Information Services |
| Market Cap | $11.05B | $27.90B |
| Revenue (TTM) | $176M | $19.95B |
| Net Income (TTM) | $-117M | $1.50B |
| Gross Margin | 92.7% | 42.5% |
| Operating Margin | -36.4% | 12.5% |
| Forward P/E | — | 12.4x |
| Total Debt | $22M | $10.00B |
| Cash & Equiv. | $45M | $4.51B |
Quick Verdict: HTFL vs GEHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HTFL is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 39.9%, EPS growth 8.1%
- 4.3% 10Y total return vs GEHC's 2.9%
- Lower volatility, beta 2.00, Low D/E 7.3%, current ratio 5.20x
GEHC carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 3 yrs, beta 1.37, yield 0.2%
- Beta 1.37, yield 0.2%, current ratio 1.18x
- 7.5% margin vs HTFL's -66.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 39.9% revenue growth vs GEHC's 4.8% | |
| Quality / Margins | 7.5% margin vs HTFL's -66.3% | |
| Stability / Safety | Beta 1.37 vs HTFL's 2.00 | |
| Dividends | 0.2% yield; 3-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +4.3% vs GEHC's -10.7% | |
| Efficiency (ROA) | 4.1% ROA vs HTFL's -43.8%, ROIC 13.3% vs -17.3% |
HTFL vs GEHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HTFL vs GEHC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
Evenly matched — HTFL and GEHC each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEHC is the larger business by revenue, generating $20.0B annually — 113.4x HTFL's $176M. GEHC is the more profitable business, keeping 7.5% of every revenue dollar as net income compared to HTFL's -66.3%. On growth, HTFL holds the edge at +40.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $176M | $20.0B |
| EBITDAEarnings before interest/tax | -$55M | $3.3B |
| Net IncomeAfter-tax profit | -$117M | $1.5B |
| Free Cash FlowCash after capex | -$59M | $1.5B |
| Gross MarginGross profit ÷ Revenue | +92.7% | +42.5% |
| Operating MarginEBIT ÷ Revenue | -36.4% | +12.5% |
| Net MarginNet income ÷ Revenue | -66.3% | +7.5% |
| FCF MarginFCF ÷ Revenue | -33.5% | +7.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +40.5% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +51.9% | -30.9% |
Valuation Metrics
GEHC leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $11.0B | $27.9B |
| Enterprise ValueMkt cap + debt − cash | $11.0B | $33.4B |
| Trailing P/EPrice ÷ TTM EPS | -21.88x | 13.48x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 19.78x |
| EV / EBITDAEnterprise value multiple | — | 10.00x |
| Price / SalesMarket cap ÷ Revenue | 62.77x | 1.35x |
| Price / BookPrice ÷ Book value/share | 36.75x | 2.66x |
| Price / FCFMarket cap ÷ FCF | — | 18.53x |
Profitability & Efficiency
GEHC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEHC delivers a 14.4% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-39 for HTFL. HTFL carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to GEHC's 0.94x. On the Piotroski fundamental quality scale (0–9), HTFL scores 5/9 vs GEHC's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -38.8% | +14.4% |
| ROA (TTM)Return on assets | -43.8% | +4.1% |
| ROICReturn on invested capital | -17.3% | +13.3% |
| ROCEReturn on capital employed | -31.9% | +10.8% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.07x | 0.94x |
| Net DebtTotal debt minus cash | -$23M | $5.5B |
| Cash & Equiv.Liquid assets | $45M | $4.5B |
| Total DebtShort + long-term debt | $22M | $10.0B |
| Interest CoverageEBIT ÷ Interest expense | -4.71x | 5.35x |
Total Returns (Dividends Reinvested)
HTFL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HTFL five years ago would be worth $10,428 today (with dividends reinvested), compared to $10,293 for GEHC. Over the past 12 months, HTFL leads with a +4.3% total return vs GEHC's -10.7%. The 3-year compound annual growth rate (CAGR) favors HTFL at 1.4% vs GEHC's -8.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +3.5% | -25.9% |
| 1-Year ReturnPast 12 months | +4.3% | -10.7% |
| 3-Year ReturnCumulative with dividends | +4.3% | -22.2% |
| 5-Year ReturnCumulative with dividends | +4.3% | +2.9% |
| 10-Year ReturnCumulative with dividends | +4.3% | +2.9% |
| CAGR (3Y)Annualised 3-year return | +1.4% | -8.0% |
Risk & Volatility
Evenly matched — HTFL and GEHC each lead in 1 of 2 comparable metrics.
Risk & Volatility
GEHC is the less volatile stock with a 1.37 beta — it tends to amplify market swings less than HTFL's 2.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HTFL currently trades 72.7% from its 52-week high vs GEHC's 68.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.00x | 1.37x |
| 52-Week HighHighest price in past year | $41.22 | $89.77 |
| 52-Week LowLowest price in past year | $20.13 | $58.75 |
| % of 52W HighCurrent price vs 52-week peak | +72.7% | +68.3% |
| RSI (14)Momentum oscillator 0–100 | 56.6 | 32.1 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 4.3M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates HTFL as "Buy" and GEHC as "Buy". Consensus price targets imply 36.9% upside for GEHC (target: $84) vs 26.8% for HTFL (target: $38). GEHC is the only dividend payer here at 0.23% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $38.00 | $84.00 |
| # AnalystsCovering analysts | 4 | 18 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% |
| Dividend StreakConsecutive years of raises | — | 3 |
| Dividend / ShareAnnual DPS | — | $0.14 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.7% |
GEHC leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). HTFL leads in 1 (Total Returns). 2 tied.
HTFL vs GEHC: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is HTFL or GEHC a better buy right now?
For growth investors, Heartflow, Inc.
Common Stock (HTFL) is the stronger pick with 39. 9% revenue growth year-over-year, versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). GE HealthCare Technologies Inc. (GEHC) offers the better valuation at 13. 5x trailing P/E (12. 4x forward), making it the more compelling value choice. Analysts rate Heartflow, Inc. Common Stock (HTFL) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HTFL or GEHC?
Over the past 5 years, Heartflow, Inc.
Common Stock (HTFL) delivered a total return of +4. 3%, compared to +2. 9% for GE HealthCare Technologies Inc. (GEHC). Over 10 years, the gap is even starker: HTFL returned +4. 3% versus GEHC's +2. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HTFL or GEHC?
By beta (market sensitivity over 5 years), GE HealthCare Technologies Inc.
(GEHC) is the lower-risk stock at 1. 37β versus Heartflow, Inc. Common Stock's 2. 00β — meaning HTFL is approximately 46% more volatile than GEHC relative to the S&P 500. On balance sheet safety, Heartflow, Inc. Common Stock (HTFL) carries a lower debt/equity ratio of 7% versus 94% for GE HealthCare Technologies Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — HTFL or GEHC?
By revenue growth (latest reported year), Heartflow, Inc.
Common Stock (HTFL) is pulling ahead at 39. 9% versus 4. 8% for GE HealthCare Technologies Inc. (GEHC). On earnings-per-share growth, the picture is similar: Heartflow, Inc. Common Stock grew EPS 8. 1% year-over-year, compared to 4. 8% for GE HealthCare Technologies Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HTFL or GEHC?
GE HealthCare Technologies Inc.
(GEHC) is the more profitable company, earning 10. 1% net margin versus -66. 3% for Heartflow, Inc. Common Stock — meaning it keeps 10. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEHC leads at 13. 4% versus -36. 4% for HTFL. At the gross margin level — before operating expenses — HTFL leads at 76. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is HTFL or GEHC more undervalued right now?
Analyst consensus price targets imply the most upside for GEHC: 36.
9% to $84. 00.
07Which pays a better dividend — HTFL or GEHC?
In this comparison, GEHC (0.
2% yield) pays a dividend. HTFL does not pay a meaningful dividend and should not be held primarily for income.
08Is HTFL or GEHC better for a retirement portfolio?
For long-horizon retirement investors, GE HealthCare Technologies Inc.
(GEHC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Heartflow, Inc. Common Stock (HTFL) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (GEHC: +2. 9%, HTFL: +4. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between HTFL and GEHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HTFL is a mid-cap high-growth stock; GEHC is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.